Emblem Corp did not request this Q&A or any content coverage. No compensation or consideration was offered or received. This Q&A was initiated by CannaInvestor Magazine.
Nick … it’s been too long since CannaInvestor has had a Q&A with Emblem. There is a lot to discuss and not a lot of time and I know how busy you are as we march towards October 17th as an industry. Most investors understand what an LP is so let’s not get into that but Emblem does have somewhat of a unique structure with three business lines. Emblem Cannabis, Emblem Pharmaceutical, and Grow-Wise Health. Succinctly, what are these three business lines and how do they contribute to the success of Emblem and by extension to your patients, customers, and shareholders/investors?
EMC:
CCIM:
DISCLOSURE
Hi Louis, first of all, thank you for having us participate in this Q&A session. We agree that it’s been too long since we last provided an update.
Let me clarify something else… since I’ve joined Emblem, we’ve repositioned the business into three distinct verticals; Cultivation, Medical, and Adult-use. With the evolving sector, this structure best positions Emblem to capitalize on all of the rich opportunities ahead.
352